Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-123712
Filing Date
2022-04-27
Accepted
2022-04-27 16:32:03
Documents
5
Period of Report
2022-06-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A d288879ddef14a.htm DEF 14A 338276
2 GRAPHIC g288879g01a01.jpg GRAPHIC 37777
3 GRAPHIC g288879g02a02.jpg GRAPHIC 37777
4 GRAPHIC g288879g27k39.jpg GRAPHIC 151121
5 GRAPHIC g288879g27k40.jpg GRAPHIC 156506
  Complete submission text file 0001193125-22-123712.txt   857777
Mailing Address 50 NORTHERN AVE. BOSTON MA 02210
Business Address 50 NORTHERN AVE. BOSTON MA 02210 857-343-8292
Ikena Oncology, Inc. (Filer) CIK: 0001835579 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40287 | Film No.: 22860169
SIC: 2836 Biological Products, (No Diagnostic Substances)